Riskpilot← Back to searchSign inGet full accessRØROS DYREKLINIKK AS
ASActiveOrg 998552966Tollef Bredals Vei 13, 7374 RørosVeterinary activities · NACE 7500Est. 201212 employees
Revenue 2024
NOK 8,2M
+5% vs 2023
EBITDA margin
2.9%
-53% vs 2023
Equity ratio
50.8%
Financial strength
Net profit 2024
NOK 169K
-54% vs 2023
| Revenue | NOK 8,2M | +5% |
| EBITDA | NOK 236K | -53% |
| Net profit | NOK 169K | -54% |
| Total assets | NOK 1,9M | +12% |
| Equity | NOK 945K | +22% |
| Employees | 12 | — |
Legal name
RØROS DYREKLINIKK AS
Org number
998552966
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
27. juni 2012
Share capital
NOK 30 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Tilby klinisk veterinærpraksis og rådgivningstjenester for selskapsdyr, hest og produksjonsdyr.
Address
Tollef Bredals Vei 13, 7374 Røros
Phone
+4772412740
Email
post@rorosdyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 573 | 5 872 | 7 804 | 7 810 | 8 183 |
| Staff expenses | −2 493 | −2 836 | −3 128 | −3 203 | −3 447 |
| EBITDA | −159 | −156 | 832 | 506 | 236 |
| Depreciation & amort. | −42 | −29 | −20 | −28 | −28 |
| EBIT | −201 | −185 | 812 | 478 | 208 |
| Net financials | −14 | −20 | −19 | −4 | 9 |
| Profit before tax | −215 | −204 | 793 | 474 | 217 |
| Tax | −52 | −43 | 175 | 104 | 48 |
| Net profit | −164 | −161 | 619 | 369 | 169 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 027 | 921 | 1 572 | 1 668 | 1 861 |
| Equity | −52 | −213 | 406 | 775 | 945 |
| Long-term debt | 371 | 297 | 221 | 0 | 0 |
| Short-term debt | 707 | 837 | 945 | 893 | 916 |
| Total debt | 1 079 | 1 134 | 1 167 | 893 | 916 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20202024
Equity ratio
50.8%
This company
38.2%
Market median
+33% vs market
20202024
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20202024
Asset turnover
4.40×
This company
1.12×
Market median
+293% vs market
20202024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2018 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RØROS DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ida Mari Devle | Chief Executive Officer | 0 companies |
| Marit Evanger | Chairman | 0 companies |
| Marit Ose | Board of Directors | 0 companies |
| Stig Schjerven Østgård | Board of Directors | 0 companies |
| Gunn Nylend Axthorne | Board of Directors | 0 companies |
| Jon Frydenborg | Board of Directors | 0 companies |